NCT06494046

Brief Summary

This study evaluates the experience of musicians who are going through cancer treatment.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 10, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2025

Completed
Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

9 months

First QC Date

July 2, 2024

Last Update Submit

May 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Describe specific musical difficulties that arise during and after cancer treatments - MTQ 10-item

    Assessed using the Musical Toxicity Questionnaire (MTQ 10-item), a survey with yes/no and open-ended questions (e.g., What musical instrument do you play, or do you sing?). The survey is designed to capture the participant's thoughts and feelings on how cancer treatments (before and after) has affected enjoyment and ability to play, teach, or perform music. The questionnaire will take about 15-30 minutes to complete. Qualitative analysis software will be utilized to code responses and organize themes. Themes will be organized into related groups and interpreted to generate conclusions.

    Baseline

Study Arms (2)

Observational Musical Toxicity Group

Patients complete a questionnaire, participate in an interview and their medical records reviewed on study.

Other: Non-Interventional Study

Observational No Musical Toxicity Group

Patients have their medical records reviewed on study.

Other: Non-Interventional Study

Interventions

Non-Interventional Study

Observational Musical Toxicity GroupObservational No Musical Toxicity Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are active or accomplished musicians undergoing cancer treatment.

You may qualify if:

  • \* Adults ≥ 18 years or older
  • Active or accomplished musicians
  • Those performing in the community as part of a group or as a soloist
  • Those teaching lessons in an individual or group setting
  • Those for whom music teaching or performance is a primary source of income
  • Those who play music multiple times per week
  • Our ideal cohort will consist of an equal number of patients with the following malignancies above the diaphragm:
  • Brain
  • Head and Neck
  • Esophagus or Lung
  • Breast
  • Our ideal cohort will consist of an equal number of patients who engage in the following musical endeavors:
  • Stringed instruments
  • Wind instruments (including woodwind and brass instruments)
  • Keyboard instruments
  • +1 more criteria

You may not qualify if:

  • \* \< 18 years
  • Did not regularly attempt to engage in musical endeavors during or after cancer treatment
  • Not willing or able to complete the questionnaire or engage in a one-hour interview (i.e. limited English proficiency)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Breast NeoplasmsEsophageal NeoplasmsLung NeoplasmsBrain Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesGastrointestinal NeoplasmsDigestive System NeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesCentral Nervous System NeoplasmsNervous System NeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Dean A. Shumway, M.D.

    Mayo Clinic in Rochester

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2024

First Posted

July 10, 2024

Study Start

August 15, 2024

Primary Completion

May 19, 2025

Study Completion

May 19, 2025

Last Updated

June 4, 2025

Record last verified: 2025-05

Locations